CTN-0060-A-1: Validating 3 Substance Use Screening Tools for Adolescents

November 5, 2021 /

Sharon Levy, MD, MPH
Lead Investigator
Harvard Medical School
Boston Children’s Hospital
sharon.levy@childrens.harvard.edu

This study seeks to test the psychometric properties of three instruments, BSTAD, S2BI, and TAPS, against a criterion standard of DSM-5 substance use disorder diagnoses in a population of adolescents presenting for routine primary care.

    Node Involvement

    Lead Node(s):

  • New England Consortium

    • All Participating Nodes:

  • New England Consortium